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Chlamydia trachomatis Tarp Harbors Distinct G and F Actin Binding
Domains That Bundle Actin Filaments
Shahanawaz Jiwani, Stephenie Alvarado, Ryan J. Ohr, Adriana Romero, Brenda Nguyen, Travis J. Jewett
Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, Florida, USA

T

he obligate intracellular bacterium Chlamydia trachomatis
causes the most frequently reported sexually transmitted bacterial disease in the United States, with over 1 million cases reported to the Centers for Disease Control and Prevention annually
(1). Worldwide, ocular infection with C. trachomatis (trachoma)
is the leading cause of preventable blindness and is the subject of a
global initiative led by the World Health Organization to eradicate
trachoma by 2020 (2).
Species of Chlamydia utilize a unique developmental cycle in
which bacteria transition from the infectious spore-like elementary body (EB) to the metabolically active reticulate body (RB)
within the protective confines of a membrane-bound parasitophorous vacuole termed the inclusion (3). The invasive EB is
formed in the middle to late stages of the intracellular development cycle as the RBs differentiate back to EBs and are packed with
metabolites and proteins designed to facilitate extracellular survival and reinfection (4, 5). Additional infectious cycles arise from
EBs that are released and disseminate from infected tissues (6).
C. trachomatis invasion is induced by cytoskeletal rearrangements initiated upon microbe contact with the host cell surface
(7). Alterations of the host cytoskeleton are required for bacterial
uptake, as drugs, such as cytochalasin D, that disrupt the cytoskeleton prevent C. trachomatis infections (7). A number of intracellular microorganisms harbor proteins that directly alter actin dynamics, which favor pathogen survival and propagation (8). These
virulence factors can drive the formation of actin filaments and
actin bundles or can lead to the disassembly of actin filaments.
Cytoskeletal rearrangements initiated upon EB contact with the
host cell surface may in part be triggered by the translocation of
type III secreted effectors (9, 10). One of the effector proteins,
called translocated actin recruiting protein (Tarp), is able to increase the rate of actin filament formation by directly nucleating
actin (11). In addition, Tarp and the host cell Arp2-Arp3 actinnucleating complex cooperate to increase the rate of actin filament

708

jb.asm.org

Journal of Bacteriology

formation, and both host- and bacterium-derived actin nucleators are implicated in C. trachomatis invasion (12–14).
Tarp contains a C-terminal actin binding and oligomerization
domain required for actin nucleation and an N-terminal phosphorylation domain implicated in host cell signaling via association with host-derived proteins, such as phosphoinositide 3-kinase (PI3K) and Src homology 2 (SH2) domain-containing
transforming protein 1 (SHC-1) (11, 15–17). Phosphorylated
Tarp peptides have also been shown to immunoprecipitate a complex of proteins containing Sos1 and Vav2, two Rac guanine nucleotide exchange factors thought to participate in WAVE2 and
Arp2-Arp3 complex recruitment (16). Colocalization studies of
ectopically expressed enhanced green fluorescent protein
(EGFP)-Tarp indicate that actin filament recruitment is restricted
to the C-terminal half of the effector and is presumably associated
with Tarp via the previously identified actin binding alpha helix
required for actin nucleation in vitro (14, 15). Sequence and biochemical analyses of Tarp orthologs from C. pneumoniae, C. muridarum, C. caviae, and C. trachomatis serovars A, D, and L2 revealed the presence of between 1 and 4 actin binding sites (13).
Although C. trachomatis Tarp (L2) appeared to harbor two putative actin binding domains (ABD), only one of the two alpha
helices was found to associate with actin (13). In this work, we
examined the effect of domain-specific mutations on actin filament colocalization with EGFP-Tarp. Here, we report that C. trachomatis L2 Tarp harbors two distinct filamentous-actin (F-actin)
binding sites that allow the Tarp effector to bundle actin filaments.
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All species of Chlamydia undergo a unique developmental cycle that transitions between extracellular and intracellular environments and requires the capacity to invade new cells for dissemination. A chlamydial protein called Tarp has been shown to nucleate actin in vitro and is implicated in bacterial entry into human cells. Colocalization studies of ectopically expressed enhanced green fluorescent protein (EGFP)-Tarp indicate that actin filament recruitment is restricted to the C-terminal half of the
effector protein. Actin filaments are presumably associated with Tarp via an actin binding alpha helix that is also required for
actin nucleation in vitro, but this has not been investigated. Tarp orthologs from C. pneumoniae, C. muridarum, and C. caviae
harbor between 1 and 4 actin binding domains located in the C-terminal half of the protein, but C. trachomatis serovar L2 has
only one characterized domain. In this work, we examined the effects of domain-specific mutations on actin filament colocalization with EGFP-Tarp. We now demonstrate that actin filament colocalization with Tarp is dependent on two novel F-actin binding domains that endow the Tarp effector with actin-bundling activity. Furthermore, Tarp-mediated actin bundling did not require actin nucleation, as the ability to bundle actin filaments was observed in mutant Tarp proteins deficient in actin
nucleation. These data shed molecular insight on the complex cytoskeletal rearrangements required for C. trachomatis entry
into host cells.

Tarp Bundles Actin Filaments

Furthermore, Tarp-mediated actin bundling did not require actin
nucleation, as the ability to bundle actin filaments was observed in
mutant Tarp proteins deficient in actin nucleation. These findings
attribute a novel activity to the critical Tarp protein and provide
molecular insight into the complex cytoskeletal rearrangements
required for C. trachomatis entry into host cells.
MATERIALS AND METHODS

February 2013 Volume 195 Number 4

RESULTS

Mutant Tarp proteins exhibit unique actin binding and polymerization kinetics. The actin-nucleating activity of Tarp results
from distinct actin binding and proline-rich oligomerization domains in vitro (11). C. trachomatis L2 Tarp is a large, 1,005-aa
protein, and studies to date have primarily focused on recombinant Tarp truncation mutants or Tarp peptides to identify the
domains of the protein responsible for Tarp-mediated actin polymerization (9, 11, 13). To confirm that the previously identified
domains were sufficient for actin binding and actin nucleation in
the entire Tarp effector, we generated a series of GST-His and
EGFP recombinant full-length L2 Tarp deletion mutants that are
missing the phosphorylation, the actin binding, and/or the pro-

jb.asm.org 709

Downloaded from http://jb.asm.org/ on March 21, 2019 by guest

Cloning and protein expression. In-frame amino-terminal glutathione
S-transferase (GST) and carboxyl-terminal polyhistidine fusion proteins
for full-length wild-type Tarp were generated by PCR by amplifying the
corresponding coding regions from C. trachomatis serovar L2 LGV 434
genomic DNA (Qiagen genomic purification kit; Valencia, CA) as previously described (14). PCR was performed with custom synthesized oligonucleotide primers (Integrated DNA Technologies, Coralville, IA) engineered with SalI, SacI, or NotI linkers. PCR products were purified
(Qiagen), digested with restriction enzymes (New England BioLabs, Beverly, MA), and subcloned into linearized pGEX-6P-1 to generate translational fusions with GST and polyhistidine. Tarp domain deletion mutants—phosphorylation domain deletion (⌬phoD; deletion of D125 to
Y424), proline-rich-domain (PRD) deletion (⌬PRD; deletion of S625 to
N650), actin binding domain deletion (⌬ABD; deletion of amino acids
[aa] 748 to 758), F-actin binding domain deletion 1 (⌬FAB1; deletion of
L871 to L882), and F-actin binding domain deletion 2 (⌬FAB2; deletion
of N942 to G967)—were generated by inverse PCR by amplifying the
pGEX-6P-1 plasmids encoding the wild-type Tarp fusion protein. Multiple domain deletions in a single tarP gene (for example, ⌬ABD, ⌬FAB1,
and ⌬FAB2) were generated sequentially by inverse PCR or by ligating
individual deletion mutants together. The Tarp mutants described above
were also cloned into pEGFP-C3 (BD Biosciences Clontech) to allow
ectopic expression of EGFP-Tarp in HeLa cells. All pGEX-6P-1 plasmids
were transformed into the BL21 strain of Escherichia coli (Novagen, Madison, WI). Protein expression and purification were performed according
to the procedures outlined for Ni Sepharose 6 Fast Flow and glutathione
Sepharose 4B in the Bulk GST Purification Module (GE Health Sciences,
Piscataway, NY). In some experiments, the GST tag was removed prior to
F-actin binding and bundling with PreScission Protease treatment according to the manufacturer’s recommendation (GE Health Sciences).
GST fusion pulldown experiments. GST fusion pulldown experiments were performed according to protocols previously described (11,
13). Briefly, HeLa 229 cells were suspended in 100 mM KCl, 10 mM
HEPES (pH 7.7), 2 mM MgCl2, and 2 mM ATP (buffer A) and disrupted
by sonication delivered in four consecutive bursts at 20-s intervals on
setting 4 (ultrasonic sonicator processor XL equipped with a microtip;
Misonix Incorporated, Farmingdale, NY). Insoluble material was removed by centrifugation (12,000 ⫻ g; 25 min; 4°C). Glutathione-Sepharose beads were incubated with 10 g of GST fusion proteins or GST for 1
h at 4°C in PBS (GE Health Sciences). GST fusion protein-coated beads
were washed twice with PBS and once with buffer A prior to the addition
of approximately 100 g of HeLa extract. The extracts and beads were
incubated together for 2 h at 4°C and washed three times with fresh buffer
A, and bound proteins were eluted using sample buffer.
SDS-PAGE and immunoblotting. Proteins were separated on SDS10% polyacrylamide gels and transferred to 0.45-m pure nitrocellulose
transfer and immobilization membranes (Schleicher & Schuell, Keene,
NH). Immunoblotting employed peroxidase-conjugated secondary antibodies (Chemicon International, Temecula, CA) and Supersignal West
Pico chemiluminescent substrate (Pierce, Rockford, IL). The anti-actin
C4 monoclonal antibody was purchased from Chemicon International.
The anti-phosphotyrosine 4G10 monoclonal antibody was purchased
from Upstate (Millipore). Polyclonal rabbit antibodies directed toward C.
trachomatis L2 LGV 434 Tarp (CT456) were developed at Rocky Mountain Laboratories as previously described (9). Peptide antibodies directed
toward the Tarp actin binding domain and PRD were generated and purified by Sigma Genosys (Spring, TX) as previously described (13).

Transfection of HeLa cells and indirect immunofluorescence microscopy. HeLa cells (2 ⫻ 105) were seeded in 6-well plates with coverslips
and grown for 24 h in Dulbecco’s modified Eagle’s medium (DMEM)
containing 10% fetal bovine serum (FBS). The cells were then transfected
with transfection mixture containing 8 l of Fugene HD (Promega) and
2.5 g of the respective plasmid. After 24 h, the cells were fixed by adding
4% paraformaldehyde and incubating them at 4°C for 15 min. The cells
were then treated with ice-cold 0.4% Triton X for 10 min, followed by
blocking with 5% bovine serum albumin (BSA) for 45 min. To visualize
tyrosine-phosphorylated protein, cells were first incubated with antiphosphotyrosine primary antibody 4G10 (Upstate) at 1:1,000 dilution in
0.5% BSA at room temperature (RT) for 45 min, followed by incubation
with anti-mouse secondary antibody conjugated to Alexa 350 (Invitrogen). To simultaneously visualize actin, phalloidin conjugated to Alexa
568 (Invitrogen) was added to the above-mentioned mixture containing
secondary antibodies. Coverslips were rinsed and mounted in Prolong
Gold antifade reagent (Invitrogen). The cells were examined with a Zeiss
Axio Observer A1 microscope equipped with phase-contrast and epifluorescence optics. Images were obtained using an AxioCam MRm camera
controlled by AxioVision 4.8.2 and further processed using Adobe Photoshop CS2.
F-actin binding and bundling. Briefly, 5 g of GST fusion proteins or
control proteins (GST and ␣-actinin) was added to 40 g of F actin (generated by adding 1/10 volume of polymerization buffer to globular actin
[G actin] and incubating them at RT for 1 h) and allowed to incubate at
RT for 30 min. F actin and the bound proteins were separated by differential sedimentation at 100,000 ⫻ g for 2 h at RT in a Beckman Optima
TLX Ultracentrifuge using a TLA 55 or TLA 100.3 rotor (Beckman
Coulter, Fullerton, CA). Proteins associated with the F-actin pellets were
compared to unbound proteins that remained in the supernatant by resolving the proteins on 10% SDS-polyacrylamide gels, followed by Coomassie staining. Actin-bundling experiments were performed similarly to
F-actin binding assays, except the actin bundles were isolated with a
15,000 ⫻ g spin.
Pyrene assay. Pyrene actin polymerization assays were performed as
previously described (11, 13, 14). Briefly, monomeric pyrene-labeled actin was prepared by diluting 100 g of lyophilized pyrene actin (cytoskeleton) in 2 ml of 5 mM Tris (pH 8.0)-0.2 mM CaCl2-0.2 mM ATP (G
buffer) and incubating for 1 h at RT, followed by 1 additional hour of
incubation at 4°C. Monomeric pyrene actin was obtained by collecting the
supernatant after a 2-h, 100,000 ⫻ g, 4°C spin in a Beckman Optima TLX
Ultracentrifuge using a TLA 100.3 rotor (Beckman Coulter). Approximately 20 g of pyrene-labeled actin was gently mixed with 5 g of GST
fusion proteins in a volume of 500 l for 10 min before the addition of
1/20 volume of polymerization buffer (500 mM KCl, 20 mM MgCl2, 10
mM ATP). The reaction was monitored for 1 h with an LS 55 Luminescence spectrophotometer directed by FL WinLab software version 4.0
(Perkin-Elmer, Beaconsfield, Bucks, United Kingdom) with 2.5-nm
bandwidth at 365-nm excitation wavelength and 2.5-nm bandwidth at
407-nm emission wavelength.

Jiwani et al.

the actin binding domain (red box), the proline-rich domain (blue box), and the tyrosine-rich phosphorylation domain (green boxes). ⌬ indicates amino acids
deleted in mutant Tarp proteins, and the numbers indicate amino acid positions encoded within the C. trachomatis tarP gene. Full-length and mutant Tarp
proteins were tagged with N-terminal GST tags and C-terminal histidine tags to purify recombinant protein for biochemical assays or with EGFP for immunofluorescence assays. (B) Extracts from HeLa cells were incubated with GST or GST fusions to wild-type or mutant Tarp, and specifically bound proteins were
resolved by SDS-PAGE and visualized by Coomassie blue staining (CB). GST alone and GST-Tarp fusion proteins are indicated by open circles, while the
enriched actin protein is indicated by an arrow. Specifically, Tarp proteins harboring deletions in the phosphorylation domain (⌬ phos), the proline-rich
oligomerization domain (⌬ PRD), and the actin binding domain (⌬ ABD) were tested. The HeLa lysate shown in the first lane represents 1% of the material used
in the ⫹ lysate pulldown lanes. Samples identical to those shown in the Coomassie-stained gel were subjected to immunoblotting with actin (␣ actin),
phosphotyrosine (␣ Y-PO4), and peptide antisera specific for the proline-rich (␣ PRD) and actin binding (␣ ABD) Tarp domains. The molecular masses of
protein standards are shown. (C) GST or GST-Tarp fusion proteins shown in panel B were incubated with 1 M monomeric pyrene-labeled actin. A Tarpmediated increase in actin polymerization after the addition of polymerization buffer at 300 s was measured as the arbitrary fluorescence intensity (arbitrary units
[a.u.] over time) with excitation and emission wavelengths of 365 and 407 nm, respectively. GST and pyrene actin alone served as negative controls. (D)
EGFP-Tarp mutants colocalize with filamentous actin in HeLa cells. Host cells expressing EGFP fusions of full-length Tarp (Tarp) or deletion mutants lacking
the phosphorylation domain (Tarp ⌬ Phos), proline-rich domain (Tarp ⌬ PRD), or actin binding domain (Tarp ⌬ ABD) were fixed and stained with Alexa Fluor
568-conjugated phalloidin (Actin). Host cells expressing EGFP alone or an EGFP fusion with Tarp (1 to 748) were used as negative controls.

line-rich oligomerization domain(s) to examine the contribution
that each domain makes to actin kinetics biochemically and in
HeLa cells (Fig. 1A). Wild-type Tarp and deletion mutant Tarp
proteins with dual N-terminal GST and C-terminal polyhistidine
affinity tags were purified and employed in actin binding and actin
polymerization assays (Fig. 1B and C). All full-length Tarp mutants were able to associate with host cell actin in a GST pulldown
assay, except for the ⌬ABD Tarp mutant harboring an 11-aminoacid deletion (aa 748 to 758) of the previously characterized actin

710

jb.asm.org

binding domain (Fig. 1B) (11). The purified Tarp proteins also
demonstrated distinct actin polymerization kinetics, as observed
in in vitro pyrene actin polymerization assays (Fig. 1C). An increase in the rate of actin polymerization was observed in wildtype Tarp and the Tarp effector harboring a deletion in the phosphorylation domain compared to actin-only controls, which is in
agreement with reports localizing the Tarp actin-nucleating activity to the C-terminal half of the protein (9, 11, 13, 14). Consistent
with previous studies, a short PRD of 25 amino acids, implicated
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FIG 1 Tarp deletion mutants demonstrate distinct actin binding and actin polymerization kinetics. (A) Schematics of Tarp proteins indicating the locations of

Tarp Bundles Actin Filaments

February 2013 Volume 195 Number 4

Previous studies examining the conserved domains within
Tarp orthologs demonstrated that, like C. trachomatis L2 Tarp, C.
trachomatis serovar A and D Tarps each harbored a domain that
surprisingly did not associate with G actin in GST pulldown experiments (13). In order to determine if C. trachomatis serovar A
and D Tarps harbored FAB1, GST-Tarp fusions harboring approximately 100 amino acids of each domain (C. trachomatis serovar A T940-D1040 and C. trachomatis serovar D Q820-K940)
were tested in F-actin cosedimentation experiments (Fig. 2C).
Similar to C. trachomatis L2 Tarp, the comparable protein domains within C. trachomatis serovar A and D Tarps were able to
associate with filamentous actin (Fig. 2C).
Tarp harbors multiple F-actin binding sequences. We identified a novel domain in the C-terminal region of the Tarp protein
that specifically associated with F actin, now termed FAB1. This
domain contains a 13-amino-acid peptide with similarity to the
described ABD that is also predicted to form the alpha helix secondary structure required for actin binding. In order to demonstrate that ABD and FAB1 were the two protein domains responsible for colocalization with actin filaments, EGFP-Tarp
harboring deletions of both the ABD and FAB1 were expressed in
HeLa cells (Fig. 3). Surprisingly, extopically expressed EGFP-Tarp
harboring deletions of both the ABD and FAB1 still colocalized
with actin filaments, suggesting another actin binding domain was
present in the C-terminal half of the Tarp open reading frame (Fig.
3). In order to identify the locations of additional actin binding
sites, a series of C-terminal truncations were introduced into the
EGFP-Tarp ABD and FAB1 double mutant (Fig. 3A). Truncation
mutants that lacked amino acids 955 to 1005 and 943 to 1005 were
no longer able to associate with actin filaments, suggesting an
additional actin binding domain(s) may be located in this region
of the protein (Fig. 3B). Further secondary-structure predictions
of the C-terminal domain of Tarp revealed an additional alpha
helix located between amino acids 942 and 967, although this
peptide does not share sequence similarity with the ABD and
FAB1 domains (data not shown). In order to determine if the
ABD, FAB1, and/or the additional alpha helical domain was responsible for colocalization with filamentous actin in tissue culture cells, an EGFP fusion to Tarp lacking all three alpha helical
sequences was tested for actin colocalization (Fig. 4). An EGFPTarp fusion harboring the single ABD deletion and an EGFP-Tarp
fusion harboring a double mutant lacking the ABD and the FAB1
domain were also tested (Fig. 4A). As previously observed, the ⌬ABD
mutant was able to colocalize with actin filaments, as was the double
mutant harboring both ⌬ABD and ⌬FAB1, supporting the possibility
that the third alpha helix sequence is capable of promoting F-actin
binding independently. Interestingly when all three sites were removed from Tarp, F-actin colocalization was no longer observed,
suggesting that all three sites may serve to bind F actin (Fig. 4B). Thus,
we have termed the last alpha helix F-actin binding domain 2 (FAB2).
To confirm the EGFP colocalization results, GST fusions of Tarp
(with the GST removed by PreScission protease treatment) harboring
deletions in the ABD, FAB1, and FAB2 were used to biochemically
examine cosedimentation of actin filaments with recombinant proteins. Consistent with the EGFP results, Tarp mutant proteins (with
the GST removed) demonstrated an increased reduction in their ability to cosediment with preformed actin filaments as each domain of
the protein was removed. This could be observed as both a reduction
in the quantity of Tarp mutants fractioned to the pellet and an increase in the amounts of the proteins retained in the supernatant (Fig.
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in Tarp oligomerization, was required for Tarp-mediated actin
nucleation. Deletion of PRD resulted in the creation of an actinsequestering protein (Tarp⌬PRD) that, in the pyrene actin polymerization assay, produced a curve that appeared below the actin-only and GST controls (Fig. 1C) (11). Surprisingly, when actin
filament colocalization with EGFP-Tarp was examined in HeLa
cells with Alexa-conjugated phalloidin, Tarp mutants lacking the
actin binding alpha helix, amino acids 748 to 758 (Tarp⌬ABD),
known to be essential for Tarp-mediated actin nucleation (Fig.
1C) retained the ability to colocalize with actin filaments (Fig.
1D). A Tarp-EGFP fusion lacking amino acids 749 to 1005
(Tarp⌬749-1005) did not colocalize with phalloidin and served as a
negative control (Fig. 1D). EGFP-Tarp harboring mutations in
both the phosphorylation and actin binding domains was also
found to colocalize with actin filaments (data not shown). The
actin pulldown and actin polymerization experiments differ from
the actin filament colocalization experiments in that the first two
experiments primarily use G actin, whereas the last primarily uses
F actin. These data suggest that Tarp may harbor an as yet uncharacterized F-actin binding domain(s) distinct from the previously
characterized G-actin binding domain that is essential for actin
nucleation.
C. trachomatis L2 Tarp harbors a distinct F-actin binding domain. Tarp orthologs contain between one and four actin binding
domains, according to GST pulldown assays performed with
HeLa extracts (13). Previous reports have indicated that C. trachomatis L2 Tarp harbors one actin binding domain, which is consistent with the data presented in Fig. 1B (11, 13). Deletion of 11
amino acids contained within the L2 Tarp actin binding domain
was sufficient to prevent actin binding in the GST pulldown assay
with the mutant protein compared to the wild-type control. Interestingly, bioinformatics analysis of the entire L2 Tarp protein
sequence identified a putative second actin binding domain with
sequence similarity to the experimentally characterized L2 Tarp
actin binding domain; however, this sequence lacked the ability to
associate with host cell actin in a GST pulldown assay (13). This
finding further supports the prediction that Tarp may harbor protein domains that differentiate between monomeric (globular)
actin, found predominately in the HeLa-generated protein lysates,
and filamentous actin, detected by fluorescent phalloidin in the
transfected host cells. In order to examine whether the second
actin binding-like domain found in the C. trachomatis L2 Tarp
sequence (amino acids 871 to 883) was able to differentially associate with globular versus filamentous actin, GST-Tarp fusions to
the domain were tested for their ability to associate with actin
generated from HeLa lysates in a GST pulldown assay and an
F-actin cosedimentation binding assay (Fig. 2). Similar to our previous findings, the 100-amino-acid peptide harboring the original
actin binding domain was able to associate with actin generated
from a HeLa lysate; however, the alternate putative actin binding
sequence did not associate with actin generated from the same
lysate (Fig. 2A) (11, 13). Interestingly, the two domains did cosediment with filamentous actin, indicating that the second domain preferentially associates with filamentous actin, while the
original actin binding domain is able to associate with both monomeric and filamentous actin, as previously described (Fig. 2B)
(11). Since the second actin binding sequence prefers F actin, we
have called this site F-actin binding domain 1 (FAB1) to differentiate it from the originally characterized ABD, which associates
with both G and F actin.

Jiwani et al.

4C). Tarp proteins lacking all three actin binding sites showed the
least F-actin binding (Fig. 4C).
Tarp bundles actin filaments. Tarp has previously been shown
to function as an actin nucleator (11). The actin-nucleating activity was localized to a 200-amino-acid region of the Tarp protein
sequence that was found to contain a proline-rich region responsible for protein oligomerization and a solitary actin binding domain (11). This actin binding domain was able to associate with
monomeric and filamentous actin (11). In light of the identification of two additional F-actin binding domains, we sought to examine whether the Tarp protein was capable of bundling actin
filaments (Fig. 5). Actin bundles sediment at a higher rate than
actin filaments and monomeric actin. Therefore, proteins capable
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of bundling actin filaments will appear in the pellet upon lowspeed centrifugation. Interestingly, Tarp functioned to bundle actin filaments (Fig. 5A); however, actin bundling was not dependent on Tarp-mediated actin nucleation, as the Tarp ⌬PRD
mutant, which fails to nucleate actin in vitro (Fig. 1), retained
actin-bundling activity (Fig. 5B). The Tarp triple mutant lacking
the ABD, FAB1, and FAB2 alpha helices was unable to bundle
actin filaments, which is consistent with both the EGFP colocalization and F-actin cosedimentation results (Fig. 5A).
DISCUSSION

The Tarp effector is a multifunctional protein that primes the host
cell for bacterial entry and residence. We now demonstrate that, in
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FIG 2 Tarp harbors an F-actin binding domain that is separate from the actin nucleation domain. (A) Extracts from HeLa cells were incubated with GST alone
(GST), GST fused to the Wiskott-Aldrich syndrome protein verprolin homology, cofilin homology, and acidic domain (VCA), or GST fusions to the 100-aa
fragment of Tarp containing the Tarp ABD (L2 D726-S825) or the Tarp domain containing a similar sequence (L2 P826-K940). The bound proteins were
resolved by SDS-PAGE and visualized by Coomassie blue staining. All GST fusion proteins are indicated by open circles, while the enriched actin protein is
indicated by an arrow. The HeLa lysate shown in the first lane represents 1% of the material used in the ⫹ lysate pulldown lanes. Samples identical to those shown
in the Coomassie-stained gel were subjected to immunoblotting with actin (␣-actin). (B) GST-Tarp fusions were incubated with F actin and isolated by
ultracentrifugation. Protein supernatants and pellets were resolved by SDS-PAGE and visualized by Coomassie blue staining. GST fusion proteins are indicated
by open circles and differentially appear in the supernatant and/or pellet fraction following centrifugation. The actin protein is indicated by arrows. GST-L2
D726-S825 and L2 P826-K940 precipitated with F actin in the pellet fraction, as did the positive-control protein (␣ actinin). The GST control did not associate
with the F-actin pellet and remained predominately in the supernatant. The actin shown in the first lane represents 2% of the material used in the ⫹ F actin lanes.
The molecular masses of protein standards are shown. (C) Protein domains with sequence similarity to the C. trachomatis L2 Tarp FAB1 (L2 P826-K940) from
C. trachomatis serovar A (A T940-D1040) and serovar D (D Q820-K940) were incubated with F actin and isolated by ultracentrifugation, as in panel B.

Tarp Bundles Actin Filaments

addition to the previously characterized G-actin binding/nucleating domain (11), the Tarp protein harbors two distinct F-actin
binding/bundling domains (FAB1 and -2). All three domains are
similar in that they mediate a direct link to the host cytoskeleton,
yet biochemically, they are discrete sites that specifically associate
with globular or filamentous actin. A comparison of Tarp orthologs indicates that the FAB1 and FAB2 sites are conserved
among serovars of C. trachomatis and may also be present in C.
caviae and C. muridarum. F-actin-specific binding sites might also
be found in other species, such as C. pneumoniae, but will have to
be located biochemically, as sequences of some Tarp orthologs are
more divergent, making domain comparisons more difficult to
predict.
EB attachment to the surface of an epithelial cell ultimately

February 2013 Volume 195 Number 4

results in the formation of an actin-rich pedestal at the site of
contact and is associated with bacterial invasion (7). Actin filament-destabilizing drugs, such as cytochalasin D, inhibit the formation of these projections and subsequent uptake of C. trachomatis (7). The arrangement of the actin filaments within the
pedestal is unknown, but presumably, the actin filaments form
polarized actin bundles (actin filaments sharing the same orientation with respect to their barbed [⫹] and pointed [⫺] ends) similar to those characterized in microvilli and filopodia (18). Actinbundling proteins, such as fascin 1, colocalize with filopodia on
the leading edge of the growth cones of developing nerve cells and
are implicated in the formation of actin bundles (19). Similarly,
Tarp may play a role in the formation of actin bundles located
directly beneath the invading microbe. C. trachomatis entry into
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FIG 3 Tarp harbors a second site near its C terminus that distinctly binds F actin. (A) Schematics showing a series of truncated mutants of EGFP-Tarp ⌬ABD
⌬FAB1 fusions having deletions in the C-terminal domain at increments of approximately 12 amino acids. The phosphorylation domain and proline-rich
domain are represented by green and blue boxes, respectively. ⌬ indicates amino acids deleted in the mutant Tarp proteins, and the numbers indicate amino acid
positions encoded within the C. trachomatis tarP gene. (B) EGFP-⌬ABD ⌬FAB1 Tarp mutants, as depicted in panel A, were ectopically expressed in HeLa cells
and tested for the ability to form actin aggregates that colocalize with Alexa Fluor 568-conjugated phalloidin (Actin). EGFP-⌬ABD ⌬FAB1 Tarp mutants
harboring C-terminal deletions between amino acids 966 and 1005 retained the ability to colocalize with phalloidin-stained actin, whereas EGFP-⌬ABD ⌬FAB1
Tarp mutants harboring larger C-terminal deletions that went beyond amino acid 966 of the Tarp protein did not colocalize with phalloidin-stained actin.

Jiwani et al.

expressed as either GST or EGFP fusions were examined for the ability to associate with filamentous actin. (A) Schematic of the GST- or EGFP-Tarp fusion
proteins, indicating the locations of the actin binding domain (red box), the proline-rich domain (blue box), the tyrosine-rich phosphorylation domain (green
boxes), and the newly characterized F-actin binding domains (yellow and purple boxes). ⌬ indicates amino acids deleted in the mutant Tarp proteins, and the
numbers indicate amino acid positions encoded within the C. trachomatis tarP gene. (B) Tarp mutants ectopically expressed as enhanced green fluorescent
protein fusions were examined for the ability to localize with actin filaments. Host cells expressing EGFP alone, EGFP fusions of full-length Tarp (Tarp), or
single-deletion mutants lacking the actin binding domain (Tarp ⌬ ABD), a double-deletion mutant lacking the actin binding domain and first F-actin binding
domain (Tarp ⌬ ABD ⌬ FAB1), or a triple-deletion mutant lacking the actin binding domain and both F-actin binding domains (Tarp ⌬ ABD ⌬ FAB1-2) were
fixed and stained with Alexa Fluor 568-conjugated phalloidin (Actin). (C) GST-Tarp fusions (with the GST removed by PreScission Protease treatment) were
incubated with F actin and isolated by ultracentrifugation. Protein supernatants and pellets were resolved by SDS-PAGE and visualized by Coomassie blue
staining. GST alone is indicated by open circles, while the Tarp proteins with GST removed are indicated by asterisks. GST and Tarp differentially appear in the
supernatant and/or pellet fraction following centrifugation. The actin protein is indicated by arrows. Tarp precipitated with F actin in the pellet fraction, as did
the positive-control protein (␣-actinin). Recombinant Tarp mutants harboring deletions in the ABD, FAB1, and FAB2 domains precipitated with F actin to a
lesser extent than Tarp. The GST control did not associate with the F-actin pellet and remained predominately in the supernatant. The actin shown in the first
lane represents 2% of the material used in the ⫹ F actin lanes. The molecular masses of protein standards are shown.

host cells in vitro is temperature dependent and involves the recruitment of actin to the site of EB attachment (7). Once internalized, the recruited actin quickly disseminates. The molecular details of actin disassembly are not well defined, but the process may
involve the translocation of the chlamydial effector CT694 (10).
CT694 associates with the human AHNAK protein, and ectopic
expression of CT694 in HeLa cells is associated with a reduction in
stress fibers (10). It is interesting to speculate that actin depolymerization may drive EB entry, and the recent examination of
chlamydial invasion in the presence of actin filament-stabilizing
drugs, such as jasplakinolide (Jas), supports this hypothesis, as Jas
was found to inhibit EB entry (14, 20). However, the effects of Jas
on actin filaments in vivo is controversial, as changes in cell morphology that are consistent with a reduction in filamentous actin
are observed in some Jas-treated cells (21).

714

jb.asm.org

Similar to Tarp, the Salmonella enterica serovar Typhimurium
SipC effector is able to nucleate actin and to bundle actin filaments
(22). Recently, mutant bacteria lacking the C-terminal region of
SipC responsible for F-actin binding and bundling were found to
be less invasive than wild-type Salmonella, suggesting that the
bundling activity of SipC plays a role in pathogen entry into HeLa
cells (23). Whether Tarp’s ability to bundle actin filaments also
contributes to pathogen entry is unknown but worthy of investigation, as new molecular tools continue to be developed to
examine the genetic requirements of C. trachomatis pathogenicity (24, 25).
Actin bundles are tightly controlled by a variety of actin binding proteins (ABPs) that drive specific cytoskeletal processes and
result in actin assemblies of defined thickness, length, and organization. The architecture of Tarp-mediated actin bundles has not
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FIG 4 Tarp’s ability to bind filamentous actin is dependent on two F-actin binding domains and one F- and G-actin binding domain. Tarp deletion mutants

Tarp Bundles Actin Filaments
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